Streetbeat News

Analyst Ratings

XOMA

XOMA Corporation acquired royalty and milestone rights for arimoclomol and aldoxorubicin from LadRx Corporation for $5 million. Arimoclomol is expected to file a New Drug Application in Q3 2023, while aldoxorubicin is in Phase 2 development for pancreatic cancer. XOMA will receive royalties and milestone payments for both drugs, potentially totaling $395.6 million.

Portfolio Pulse from Vandana Singh

June 22, 2023 | 7:09 pm

BA

Susquehanna analyst Charles P. Minervino reiterated a positive rating on Boeing (NYSE:BA) with a price target of $260, citing strong demand for fuel-efficient 737 aircraft and long-term growth potential. However, he also mentioned delays in defense contracts and margin risk affecting the Defense, Space & Security segment.

Portfolio Pulse from Nabaparna Bhattacharya

June 22, 2023 | 7:04 pm

VSCO

Victoria's Secret (NYSE:VSCO) has received mixed analyst ratings in the last quarter, with an average 12-month price target of $28.57, down 32.7% from the previous average of $42.45.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 7:01 pm

FLNC

In the last 3 months, 14 analysts have provided 12-month price targets for Fluence Energy (NASDAQ:FLNC), with an average target of $26.79, up 13.18% from the previous average of $23.67.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 7:01 pm

PAGS

In the last quarter, PagSeguro Digital (NYSE:PAGS) received 3 bullish, 2 somewhat bullish, 5 indifferent, and 1 bearish analyst ratings. The average price target is $12.45, representing an upside from the current price of $10.255.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 7:01 pm

PEGA

In the last quarter, Pegasystems (NASDAQ:PEGA) received 10 analyst ratings with an average price target of $53.5, implying an upside from the current price of $49.18. The current average has increased by 10.08% from the previous average price target of $48.60.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 7:01 pm

LNG

In the last 3 months, 4 analysts have provided 12-month price targets for Cheniere Energy (AMEX:LNG), with an average target of $196.75, a 3.24% decrease from the previous average of $203.33. The company has received 2 bullish and 2 somewhat bullish ratings.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 7:00 pm

DRI

Over the past 3 months, 12 analysts have published their opinion on Darden Restaurants (NYSE:DRI) stock, with an average price target of $171.25, implying an upside from the current price of $161.79. The average price target has increased by 2.98% over the past month.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 7:00 pm

XEL

BMO Capital Markets analyst James M. Thalacker downgraded Xcel Energy Inc (NASDAQ:XEL) from Outperform to Market Perform and decreased the price target to $64 from $69 due to concerns over the lower-than-expected terms of the regulatory settlement in Colorado.

Portfolio Pulse from Lekha Gupta

June 22, 2023 | 6:58 pm

LLY

NVO

NVS

TERN

Mizuho initiated coverage on Terns Pharmaceuticals with a Buy rating and a price target of $16, implying a 35% upside. The analyst believes TERN-501 for NASH is the company's most de-risked asset and main driver of valuation. TERN-601 for obesity is considered Terns' hottest asset, while TERN-701 for chronic myeloid leukemia is the most underappreciated.

Portfolio Pulse from Vandana Singh

June 22, 2023 | 6:54 pm